3 天之前 · Robin Washington has served as a Salesforce Board Director since 2013, and Lead Independent Director since 2022, playing a critical role in Salesforce’s financial and strategic evolution. She previously served as EVP & CFO of Gilead Sciences (2008–2019), CFO of Hyperion Solutions (2006–2007), and Chief Accounting Officer of PeopleSoft.

3 天之前 · Salesforce Appoints Robin Washington as President and Chief Operating and Financial Officer. ... She previously served as EVP & CFO of Gilead Sciences (2008–2019), CFO of Hyperion Solutions ...

2 天之前 · Washington has previously been chief financial officer at Gilead Sciences and Hyperion. Salesforce on Wednesday said former Gilead Sciences finance chief Robin Washington will join the software ...

1 天前 · Washington was previously finance chief of Gilead Sciences for over 11 years before retiring in 2019. Earlier roles include CFO of Hyperion Solutions and chief accounting officer of PeopleSoft. Washington is currently on the Board of Directors of Alphabet, Eikon Therapeutics, Honeywell International and Vertiv Holdings Co.

2019年4月30日 · FOSTER CITY, Calif. -- (BUSINESS WIRE)--Apr. 30, 2019-- Gilead Sciences, Inc. (Nasdaq: GILD) announced todaythat Robin Washington, Executive Vice President (EVP) and Chief Financial Officer (CFO), plans to retire from her role, effective March 1, 2020. Ms. Washington will continue as EVP and CFO while the company works to identify a successor.

2025年1月12日 · Robin L. Washington served as the Executive Vice President and Chief Financial Officer (CFO) of Gilead Sciences, Inc., a renowned biopharmaceutical company, from May 2008 to October 2019. During her tenure at Gilead, she oversaw crucial functions such as Global Finance, Investor Relations, Facilities and Operations, and Information Technology.

Robin L. Washington has served as executive vice president and chief financial officer of Gilead Sciences, Inc., a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines to improve the care of patients with life-threatening diseases, since May 2008.

Washington served as executive vice president and chief financial officer of Gilead Sciences Inc., from May 2008 to November 2019 where she oversaw global finance, facilities and operations, investor relations, and the information technology organizations. Prior to Gilead, Washington was the CFO of Hyperion Solutions, later acquired by Oracle Corp.

2019年4月30日 · FOSTER CITY, Calif.-- ( BUSINESS WIRE )--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Robin Washington, Executive Vice President (EVP) and Chief Financial Officer (CFO), plans...

FOSTER CITY, Calif.--(BUSINESS WIRE)--April 21, 2008--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that Robin L. Washington will join the company in May 2008 as Senior Vice President and Chief Financial Officer. Ms. Washington will report to John F. Milligan, PhD, Gilead's Chief Operating Officer.